Social and Behavioral Aspects of Pharmaceutical CareCRC Press, 1996 M07 12 - 835 pages Social and Behavioral Aspects of Pharmaceutical Care takes known social and behavioral science principles and applies them to pharmacy practice. This allows readers who are training to deliver or already delivering pharmaceutical care to enhance their communication, counseling, and patient education skills. While working through this superb text, students and practitioners will develop optimal skills as problemsolvers, therapeutic consultants, patient educators, and counselors as they learn how to enhance patient compliance, negate stigma, and help patients become more comfortable with their medical situations. The instructor?s manual that comes with the text is filled with exercises that highlight the most important aspects of each chapter and engages readers in the content of each chapter.Readers who approach this text with a real desire to better understand how behavior links to the complexities of an individual?s or social group?s actions and deeds will find it exhilarating reading as they gain a better understanding of and appreciation for pharmaceutical care and its behavioral underpinnings. Also, instead of offering only a few definitive answers, Social and Behavioral Aspects of Pharmaceutical Care contains extensive descriptions of phenomena known to be true but which are all subject to change when new variables are introduced. This helps readers become more aware of and comfortable with the “gray” areas of pharmacy.Authors in Social and Behavioral Aspects of Pharmaceutical Care take pieces of the complex web of pharmaceutical care, describe known microcosmic components of such care, and then relate the pieces back to the integrity of the web. Readers will find that the behavior of the patient, the prescriber, the systems that allow for these interactions, and, ultimately, the outcomes of medication use are in fact, not as simple as they may appear. Readers learn to deal with these complexities by improving their interactive skills in these areas:
|
Contents
CONCEPTS OF HEALTH AND ILLNESS | 3 |
Illness Sickness and Disease | 21 |
The Meaning of Signs and Symptoms | 41 |
Does | 46 |
Fever | 56 |
Acute vs Chronic Problems | 65 |
CHOOSING A SOURCE OF CARE | 85 |
Other Health Providers and the Pharmacist | 99 |
Fever | 454 |
Childrens MedicineRelated Beliefs and Behaviors | 456 |
Sore throat | 460 |
Helping Children Learn About Medicines | 464 |
Blood in urine | 469 |
Adolescents and College Students | 473 |
SelfCare Activities | 483 |
Health Services Utilization | 491 |
The Adaptation of Medicine | 105 |
The Practice of Dentistry | 111 |
Unorthodox Healing Systems | 123 |
Hydrotherapy | 131 |
FOOD | 133 |
Wave and Radiation | 137 |
SelfExercise | 143 |
CHOOSING A THERAPEUTIC AGENT | 149 |
Methods Used to Influence Prescribing | 159 |
49 | 179 |
Pharmacists Performance in Drug Product | 185 |
Therapeutic Interchange | 197 |
Conclusions | 207 |
Interprofessional Relations in Drug Therapy | 213 |
Barriers to Interprofessional Relations | 222 |
Patient Prescriber Pharmacist | 230 |
Conclusion | 245 |
Consumer Behavior | 254 |
Prescription Medications and Consumer Goods | 261 |
Prescription Medication Use | 271 |
Providing Pharmaceutical Care to Medication Consumers | 285 |
MEDICATIONTAKING BEHAVIOR | 295 |
Predicting and Detecting Noncompliance | 323 |
Blood in urine | 331 |
Explaining and Changing Noncompliant | 351 |
33333 | 359 |
Changing Noncompliant Behavior | 362 |
Compliance Enhancement in Tomorrows World | 370 |
OUTCOMES OF PHARMACEUTICAL CARE | 379 |
Economic Outcomes | 385 |
Types of Economic Analyses | 392 |
Critical Evaluation of the Health Economic Literature | 398 |
Questionnaire PSQ18 | 431 |
Children and Medicines | 449 |
Compliance in Adolescents | 498 |
Conclusion | 505 |
Ambulatory Elderly | 515 |
General Health Concerns | 522 |
Conclusion and Commentary | 531 |
Social | 537 |
An Overview | 544 |
Conclusion | 555 |
A Conceptual Basis of Care | 563 |
Conclusion | 579 |
Back pain | 581 |
Pharmaceutical Care of Terminally | 585 |
Mental Disorders | 611 |
Selected Psychosocial Principles of Mental Disorder | 619 |
Principles of Longitudinal Monitoring | 627 |
Cultural Issues in the Practice of Pharmacy | 635 |
Culturally Sensitive Practices | 641 |
Public Policy | 651 |
The Demand for and Supply of Public Policy | 657 |
The Rebirth of Cognitive Services | 675 |
What Is Image? | 685 |
Gaining Reimbursement for Cognitive Services | 691 |
Conclusion | 706 |
Recent Developments in Behavioral Medicine | 715 |
Expectations Education and Technology | 737 |
Corporate Image | 747 |
Technology | 749 |
in Pharmacy | 757 |
Conclusion | 764 |
Strategies for Image Improvement | 769 |
Ethical Concerns in Drug Research | 773 |
Epilogue | 801 |
809 | |
Other editions - View all
Social and Behavioral Aspects of Pharmaceutical Care Nathaniel Rickles,Albert Wertheimer,Mickey Smith No preview available - 2010 |
Common terms and phrases
activities administration adolescents adverse drug reactions alternative analgesics assessment associated attitudes benefits bioequivalence Bootman brand-name chronic cists Clin clinical pharmacy cognitive services community pharmacists compliance consumer costs cultural decisions developed digoxin disease dispensing doctor dose drug information drug product selection drug therapy elderly evaluation example factors formulary guidelines health behavior Health Belief Health Belief Model health care system health maintenance organization health professionals Hosp Pharm hospice care hospital hypertension illness impact important improve increased individual influence prescribing interactions interventions involved issues long-term macists measure medication ment monitoring noncompliance nursing organizations outcomes pain patient satisfaction payers person phar pharmaceutical pharmacists pharmacoeconomic pharmacy practice pharmacy services physician potential practitioners problems programs regimen relationship reported response result role self-care self-medication self-treatment side effects social specific symptoms therapeutic interchange tion treatment
Popular passages
Page 797 - In any research on human beings, each potential subject must be adequately informed of the aims, methods, anticipated benefits and potential hazards of the study and the discomfort it may entail. He or she should be informed that he or she is at liberty to abstain from participation in the study and that he or she is free to withdraw his or her consent to participation at any time.
Page 797 - In that case the informed consent should be obtained by a doctor who is not engaged in the investigation and who is completely independent of this official relationship. 11. In case of legal incompetence, informed consent should be obtained from the legal guardian in accordance with national legislation. Where physical or mental incapacity makes it impossible to obtain informed consent, or when the subject is a minor, permission from the responsible relative replaces that...
Page 797 - When obtaining informed consent for the research project the physician should be particularly cautious if the subject is in a dependent relationship to him or her or may consent under duress.
Page 797 - The research protocol should always contain a statement of the ethical considerations involved and should indicate that the principles enunciated in the present Declaration are complied with.